Oxford BioDynamics Plc OXBOF
Set alert
At close · Oct 30
- YTD
- 0.00%
- 1 year
- -72.00%
- Open
- 0.0015
- Prev close
- 0.0014
- Mkt cap
- 18.82M
- Vol
- 174.57K
- Avg vol
- 6.98K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0014
- High
- 0.0015
News
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics shares soar 33% after unveiling breakthrough blood test for Chronic Fatigue Syndrome
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) shares surged 33% on Wednesday after the company announced it had developed a highly accurate blood test to diagnose Chronic Fatigue Syndrome, a condition…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics unveils blood test for Chronic Fatigue Syndrome with 96% accuracy
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) has developed what it calls a “first-in-class” blood test to diagnose Chronic Fatigue Syndrome, a breakthrough that could help end years of uncertainty for…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics shares climb blood test findings
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) shares strengthened on Thursday, after the health diagnostics company reported that its EpiSwitch CiRT blood test was shown to influence clinical decisions…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics partners with Google Cloud - ICYMI
Oxford BioDynamics PLC (AIM:OBD, OTC:OXBOF) executive chairman Iain Ross talked with Proactive about the company's new partnership with Google Cloud, a move he described as a major growth catalyst…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics soars on new Google collab
Oxford BioDynamics PLC (AIM:OBD) shares soared in early deals, as it unveiled a new collaboration with Google Cloud. In the project, they plan to develop and deploy Oxford BioDynamics' EpiSwitch…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics shares jump 66% after Pfizer validates blood-based cancer biomarker technology
Oxford BioDynamics PLC (AIM:OBD) shares jumped 66% after Pfizer published data confirming the effectiveness of the company's EpiSwitch blood-based biomarkers in monitoring tumour status and treatment…
1 year ago proactiveinvestors.co.uk
Oxford BioDynamics shares jump on UK lab accreditation for flagship cancer test
Shares in Oxford BioDynamics PLC (AIM:OBD) rose as much as 9% in early trading on Friday after the company announced that its Oxford-based facility has been accredited by the UK's national…
2 years ago proactiveinvestors.co.uk
Oxford BioDynamics slumps on warning of need for new funding
Oxford BioDynamics PLC (AIM:OBD) shares tumbled over 37% on Monday as the precision medicine test developer warned new funding would be needed by early next year. Plans were announced for senior…
2 years ago businesswire.com
Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy
OXFORD, England--(BUSINESS WIRE)-- #EpiSwitch--Oxford BioDynamics, Plc (AIM: OBD, the Company), a precision clinical diagnostics company bringing specific and sensitive tests to the practice of…
2 years ago proactiveinvestors.com
Oxford Biodynamics tumbles as results knock froth off recent gains
Shares in Oxford BioDynamics PLC (AIM:OBD) tumbled 23% to 26p, wiping out gains made in the past week, after it published results that were in line with most expectations. The company, which has…